drugset / Trial / NCT00153127

Comparison of PolyethyleneGlycol and Placebo for Relief of Constipation From Constipating Medications

NCT00153127

Phase 4 Completed 100 enrolled Braintree Laboratories
RandomizedParallel-groupDouble-blind

Summary

The purpose of this study is to assess treatment responses comparing a newly FDA-approved PEG laxative versus placebo.

Timeline

Start
2001-11
Primary completion
2004-09
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject polyethylene glycol Other / unclassified

Indications